Shift4 at $38 after the guidance cut
Shift4 cut 2026 guidance after travel disruption, European fee concessions and currency reduced Q4 revenue expectations by roughly $54 million.
Shift4 cut 2026 guidance after travel disruption, European fee concessions and currency reduced Q4 revenue expectations by roughly $54 million.
@MBrooks87621 $tenb
Activist Nelson Peltz Walked Away From the Investment He Loved Most. Now He’s Back. $WEN
@BryanFaulkCPA I bought the $PSA preferred and the $VNO preferred recently They have pretty good price appreciation on top on the solid yield now
Prenetics' Q3 revenue rose 3.3x to $64.1 million as IM8 acquisition spending widened EBITDA losses; management targets a 3-to-1…
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual…
NIQ Global Intelligence grew Q3 Intelligence subscription revenue 5.5% and adjusted EBITDA 17.8%, cutting net leverage to 2.9x while…
Strategy, BitMine, Sharplink and Hyperliquid Strategies traded at 14% to 33% discounts to token NAV on November 18, 2026, testing buy-wide,…
Adient has $435 million of buyback capacity, equal to 38% of its market value, after adding $400 million to its repurchase program.
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets…
AST SpaceMobile’s 79% decline improves its risk-reward case, but satellite deployment delays, rising costs and Blacklift commitments raise…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
IOND · long Ionic Digital (IOND) is pitched as a legacy bitcoin miner shifting into AI infrastructure, with Nscale’s Microsoft-backed, NVIDIA-linked…
ResMed benefits as Eli Lilly-funded sleep-apnoea diagnoses expand PAP demand, while NOV’s geothermal cutters and Po Valley’s unhedged…
Kestra Medical’s growth was flattered by reserve benefits, while weak WCD compliance and Element’s Jewel patch threaten ASSURE’s advantage.
Kronos Worldwide’s 27% inventory reduction added $120 million in cash inflows as chloride-based TiO₂ demand rises amid a sulfur shortage.
ZIM’s proposed deal carries a claimed 23% spread and 110% IRR by Q4 2026, with Q3 and Q4 dividends potentially raising returns if closing…
Turning Point Brands reaffirmed 2026 guidance after a CEO change, while ALP and FRE expansion has compressed margins through marketing and…
Micron’s customer agreements, Analog Devices’ acquisitions, Ondas’ GATE deal and Baker Hughes’ power systems position them for AI…
New Era Energy & Digital secured a 20-year Vistra power deal for 200 to 207 MW, reducing Phase 1 risk for its planned 1.4 GW West Texas AI…
Shift4 trades at 6.5x EBITDA despite 11% reported organic growth, with Shift4 Dine equipment leases cited as evidence of net-new merchant…
Texas Instruments, ON Semiconductor and Vishay are rated Accumulate on rising robotics demand for analog, power and discrete chips after a…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.